Arrow keys move between marks; Enter selects; F opens full screen.

Skip to content
Procura
Get started
Organogenesis Inc.Report or remove this logo

Organogenesis Inc. Federal Contracts

Correct this listing

UEIUEI: the 12-character ID the government gives every company registered for federal work. It replaced the DUNS number in April 2022. Glossary VKK3WXM4RCZ7· CAGECAGE code: a 5-character code that identifies one company location for federal work. A company with several sites can have several. Glossary 4JB06· CANTON, MA· Active registration until Aug 18, 2027· www.organogenesis.com (opens in a new tab)

Overview

Buyers and offices that award Organogenesis prime contracts, US$, active FY2021–FY2026

Obligated since award on contracts active FY2021–FY2026

Click a company to open its profile.

Buyers (sub-agency)OfficesThis companyDefense Logistics Agency$461KVeterans Affairs$20.7KDLA TROOP SUPPORT (SPE2D6)$461K · Defense Logistics Agency office261-NETWORK CONTRACT OFFICE 21(36C261)$11.9K · Veterans Affairs office250-NETWORK CONTRACT OFFICE 10(36C250)$8,850 · Veterans Affairs office1 more offices$0Organogenesis Inc.$482K
Awards toSubcontracts toCircle area = dollars

Insight DLA TROOP SUPPORT (SPE2D6) is its largest buyer. See more on the Buyers tab

4 buying offices

Prime contract obligationsObligation: money the government has legally committed to a contract. It is not the same as money paid. Example: $6M obligated of a $10M ceiling. Glossary, FY2006–FY2026

$7.96M

Includes FY2026 so far: $40.4K, still being reported

Subcontracts it received

$34.7K

from 1 prime

About

From the company's SBA profile, updated Aug 2026

We are a leading regenerative medicine company focused on the development, manufacture and commercialization of solutions for the Advanced Wound Care and Surgical & Sports Medicine markets. Our products have been shown through clinical studies to support and in some cases accelerate tissue healing and improve patient outcomes. We are advancing the standard of care in the healing process through multiple breakthroughs in tissue engineering and cell therapy. Our solutions address large and growing markets driven by aging demographics and increases in comorbidities such as diabetes, obesity, cardiovascular and peripheral vascular disease and smoking. We offer our differentiated products and in-house customer support to a wide range of health care customers. Our mission is to provide integrated healing solutions that substantially improve medical outcomes and the lives of patients while lowering the overall cost of care. For more info, please visit us at http://www.organogenesis.com.

Prime contract obligations by fiscal year, US$, FY2006–FY2026

Agencies report with a delay; the latest year will rise

Hover over a year to see its value.

FY06FY08FY10FY12$1.23MFY14FY16FY18FY20FY22FY24FY26FY26 so far: $40.4K

Insight Largest year: $1.23M in FY2013; since FY2021, $286K in FY2025. See more on the Contracts tab

Prime obligations since award by state of performance, US$, contracts active FY2021–FY2026

$482K since award = $464K in FY2021–FY2026 + $17.9K before FY2021

Click a state to open its page.

AKMEVTNHWAIDMTNDMNILWIMINYRIMAORNVWYSDIAINOHPANJCTCAUTCONEMOKYWVVAMDDEAZNMKSARTNNCSCDCOKLAMSALGAHITXFLPR
  1. Massachusetts$482K · 100%
Circle area = dollarsOutlined: head office state (Massachusetts)

Insight 100% was performed in Massachusetts. See more on the Contracts tab